Evidence map›Paper›PMID 34440452›Full record

ArticleGenes2021

Benefits of Exome Sequencing in Children with Suspected Isolated Hearing Loss.

Roxane Van Heurck, Maria Teresa Carminho-Rodrigues, Emmanuelle Ranza, Caterina Stafuzza, Lina Quteineh, Corinne Gehrig, Eva Hammar, Michel Guipponi, Marc Abramowicz, Pascal Senn and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Mastering genetics for your clinic: A step-by-step guide.The Journal of allergy and clinical immunology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. AFrontiers in genetics · 2023
    Article
  14. Spectrum of Genes for Non-International journal of molecular sciences · 2022
    Article
  15. De novo variants are a common cause of genetic hearing loss.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Roxane Van HeurckDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Maria Teresa Carminho-RodriguesDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Emmanuelle RanzaDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Caterina StafuzzaEar-Nose-Throat/Head and Neck Surgery Division, Geneva University Hospitals, 1205 Geneva, Switzerland.
Lina QuteinehDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Corinne GehrigDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Eva HammarDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Michel GuipponiDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Marc AbramowiczDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Pascal SennEar-Nose-Throat/Head and Neck Surgery Division, Geneva University Hospitals, 1205 Geneva, Switzerland.ORCID 0000-0002-4619-3341
Nils GuinandEar-Nose-Throat/Head and Neck Surgery Division, Geneva University Hospitals, 1205 Geneva, Switzerland.
Helene Cao-VanEar-Nose-Throat/Head and Neck Surgery Division, Geneva University Hospitals, 1205 Geneva, Switzerland.
Ariane Paoloni-GiacobinoDivision of Genetic Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.ORCID 0000-0001-9432-1785
University Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHearing loss is characterized by an extensive genetic heterogeneity and remains a common disorder in children. Molecular diagnosis is of particular benefit in children, and permits the early identification of clinically-unrecognized hearing loss syndromes, which permits effective clinical management and follow-up, including genetic counselling.

methodsWe performed whole-exome sequencing with the analysis of a panel of 189 genes associated with hearing loss in a prospective cohort of 61 children and 9 adults presenting mainly with isolated hearing loss.

resultsThe overall diagnostic rate using exome sequencing was 47.2% (52.5% in children; 22% in adults). In children with confirmed molecular results, 17/32 (53.2%) showed autosomal recessive inheritance patterns, 14/32 (43.75%) showed an autosomal dominant condition, and one case had X-linked hearing loss. In adults, the two patients showed an autosomal dominant inheritance pattern. Among the 32 children, 17 (53.1%) had nonsyndromic hearing loss and 15 (46.7%) had syndromic hearing loss. One adult was diagnosed with syndromic hearing loss and one with nonsyndromic hearing loss. The most common causative genes were STRC (5 cases), GJB2 (3 cases), COL11A1 (3 cases), and ACTG1 (3 cases).

conclusionsExome sequencing has a high diagnostic yield in children with hearing loss and can reveal a syndromic hearing loss form before other organs/systems become involved, allowing the surveillance of unrecognized present and/or future complications associated with these syndromes.

Indexed as

ActinsAdultChildChild, PreschoolCollagen Type XIConnexin 26DeafnessExomeExome SequencingFemaleHearing Loss, SensorineuralHumansIntercellular Signaling Peptides and ProteinsMaleMutationPathology, MolecularACTG1 protein, humanActinsCOL11A1 protein, humanCollagen Type XIConnexin 26GJB2 protein, humanIntercellular Signaling Peptides and ProteinsSTRC protein, humanchildrendeafnessgeneticsisolated hearing lossmolecular diagnosiswhole-exome sequencing

Identifiers

PMID34440452
PMCPMC8391342
OpenAlexW3194084757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.